Elon Musk says he hopes brain interface technology company Neuralink will start implanting its microchips in humans next year.
Neuralink Corporation was founded in San Francisco in 2016 by Elon Musk and eight neurologists to develop implantable brain-machine interfaces. The company is now known to have developed a chip that will be implanted into people’s brains to record and stimulate brain activity. It is said to be intended to have medical applications such as the treatment of spinal cord injuries and neurological disorders.
Elon Musk is hopeful of Neuralink!
In an interview broadcast live monday at The Wall Street Journal CEO Council Summit, Musk was asked what Neuralink plans to do in 2022. Musk responded:
Neuralink works well with monkeys. We’ve also increased the number of tests considerably. We confirm that it is safe to use and subsequently remove. This will include people with serious spinal cord injuries, such as tetraplegics and quadriplegics, next year. We hope the FDA will approve the matter.
Following that conversation, Musk said Neuralink’s “device placement standards are much higher than the FDA requires.” “Next year, progress will accelerate when we have devices in humans (it’s hard to have nuanced conversations with monkeys),” he said in a tweet afterwards.
Musk had previously offered earlier dates for Neuralink to place its chips in humans for the first time. In 2019, for example, neuralink hopes to start human testing by the end of 2020, he said. Then, in February of this year, the company announced that it could start implanting the technology in humans by the end of 2021.
Musk therefore has a very bad reputation for making dates and putting projects on the timeline. We know you’re still doing what you put your mind to. In April, Neuralink released a video of a monkey playing a video game using a Neuralink device. So maybe they’re really ready to start manned experiments in this area.
After raising $205 million in July, Neuralink said it would direct funds to develop its chip, allowing quadriplegics (quadriplegics (quadriplegia or tetraplegia, arms and legs to be completely or partially paralyzed)to control digital devices with their minds.
Of course, Neuralink isn’t the only company developing brain interface technology. In fact, the market is getting crowded. Therefore, they may need to keep their hands fast. A 20-person biotech firm called Synchron, for example, received FDA approval to begin human testing in July.